Trump’s trade war is not the only threat to cheap PBS medicines

Australian Financial Review

10 August 2025 - Australia’s health system is rightly celebrated for its universal access and cost effectiveness, but its outdated assessment processes are hindering patient access to cutting-edge therapies.

Despite its shortcomings, the PBS has traditionally worked very effectively to keep medicine prices low for Australian consumers.

Read Australian Financial Review article

Michael Wonder

Posted by:

Michael Wonder